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Shigella spp. cause acute, debilitating
diarrheal disease in humans (particularly young
children) worldwide (1). In developing countries,
where affected populations are immunologically
compromised by poor nutrition and background
infections, deaths attributed to shigellosis are
common. Four Shigella species are recognized as
pathogenic to humans: S. sonnei, S. boydii,
S. flexneri, and S. dysenteriae. Both S. sonnei and
S. boydii are usually associated with mild illness
of short duration in which the stool may be
watery or bloody (2). S. flexneri is generally more
severe, lasts longer, and causes blood in stools.
S. dysenteriae, particularly type 1, causes the
most severe diarrheal illness, reflected in high
death rates (3). S. flexneri is a principal cause of
endemic shigellosis in many developing coun-
tries, while shigellosis in both endemic and
epidemic form has been attributed to
S. dysenteriae type 1 (2). Changes in the
worldwide epidemiology of Shigella spp. have
been documented in the last decades of the 20th
century. In industrialized regions, S. dysenteriae
was first replaced by S. flexneri, and then by
S. sonnei (4,5); S. flexneri remains the leading
cause of shigellosis in most of the developing
world (2,6-8).
In Indonesia, the last cases of S. dysenteriae
diarrhea were reported in 1985 from Jakarta
(8,9). This report, based on a study using a
systematic surveillance approach that included a
standardized detailed bacteriologic examination,
provides an Indonesia-wide geographic profile of
Shigella spp.
The Study
From June 1998 through November 1999, a
total of 3,848 children and adults seeking
treatment for debilitating diarrheal disease were
identified from eight hospital sites in Medan,
North Sumatra; Padang, West Sumatra; Batam,
Riau Island; Jakarta, Java Island; Denpasar,
Bali (two hospitals); Pontianak, West Kalimantan;
and Makassar, South Sulawesi. Rectal swabs
were obtained from patients in the study before
antibiotic therapy was administered. Specimens
were placed in Cary-Blair transport medium,
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From June 1998 through November 1999, Shigella spp. were isolated in 5% of
samples from 3,848 children and adults with severe diarrheal illness in hospitals
throughout Indonesia. S. dysenteriae has reemerged in Bali, Kalimantan, and Batam
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held at 4°C, and sent on wet ice within 2 to 4 days
after collection to the U.S. Naval Medical
Research Unit No. 2, Jakarta. Bacteriologic
evaluation was performed by standard culture
method (10). Species was confirmed by using API
20E (Biomerieux, Marcy l’Etoile, France) and
slide agglutination with specific Shigella antis-
era (Difco Laboratories, Detroit, MI). Antibiotic
susceptibility testing was accomplished by the
disk-diffusion method (11).
Overall, bacterial isolates of Shigella  spp.
were identified in 180 (5%) of 3,848 rectal swabs.
The proportional contribution of S. flexneri,
S. sonnei, and S. dysenteriae among shigellosis
cases was 80%, 12%, and 8%, respectively. No
S. boydii was detected. The percentage of
representation among the three species did not
vary substantially by geographic location.
Notable was the reemergence of S. dysenteriae in
Bali, West Kalimantan, and Batam, as well as in
Jakarta after a hiatus of >15 years (Table). The
proportional distribution of S. flexneri, S. sonnei,
and S. dysenteriae for the 5- to 12-year-old and
>12-year-old groups was similar. There appeared
to be no consistency in the seasonal distribution
patterns of Shigella spp. (Figure). S. flexneri was
the most frequently isolated organism, followed
by S. sonnei and S. dysenteriae.
Other enteric pathogens isolated were
Salmonella spp. (95, 2.5%), Vibrio cholerae (80,
2.1%), V. parahaemolyticus (38, 1%), V. cholerae
non-O1 (9, 0.2%), and Campylobacter spp. (27,
0.7%). Enterotoxigenic Escherichia coli were
detected in 225 (18.1%) of 1,240 specimens tested
by the GM1 enzyme-linked immunoassay (12). Of
the 541 specimens examined for rotavirus in the
age groups < 5 years, 191 (35.3%) were positive.
Tests to detect parasites showed Ascaris
lumbricoides in 8 (2%), Blastocystis hominis in 23
(5.6%), Giardia lamblia in 3 (0.7%), and Endolimax
nana in 2 (0.5%) of 407 stool specimens examined.
Clinical presentations associated with non-
S. dysenteriae included abdominal cramping
(79%), vomiting (56%), and fever (48%); for
S. dysenteriae, percentages of the same symp-
toms were 100%, 64%, and 27%, respectively.
Stool samples from patients with S. flexneri,
S. sonnei, and S. dysenteriae were principally
characterized by mucus in the absence of blood
(45%) or mucus and visible blood (27%).
Overall, antibiotic susceptibility patterns
showed greater resistance to ampicillin,
trimethoprim-sulfamethoxazole, chlorampheni-
col, and tetracycline for S. flexneri (85%, 59%,
82%, and 98%, respectively, from examination of
144 isolates) and S. sonnei (32%, 79%, 37%, and
100%, respectively, from examination of 22
isolates), than for S. dysenteriae (36%, 43%, 7%,
and 29%, respectively, from examination of 14
isolates). There was no evidence of resistance to
ceftriaxone, norfloxacin, ciprofloxacin, or nalid-
ixic acid, regardless of Shigella species.
Antimicrobial resistance was only apparent
among isolates obtained from Jakarta, Bali, and
Pontianak.
Conclusions
Our study showed that a substantial
proportion (5%) of acute, debilitating diarrheal
illness throughout Indonesia can be ascribed to
shigellosis; moreover, S. dysenteriae was docu-
mented from various geographic locations. Both
findings suggest that greater attention should be
paid to highlighting the endemic and epidemic
community impact of this pathogen and that
laboratory detection capabilities need to be
enhanced. Recognition of emerging and or
reemerging disease pathogens requires reliable
baseline and ongoing surveillance data.
Shifting patterns of antimicrobial-drug resis-
tance, particularly in much of the developing
world, are generally a function of overuse and
Table. Distribution of Shigella spp. from patients with diarrhea in Indonesia, June 1998 through November 1999
No. specimens No. pos. for    Proportional distribution of Shigella spp. (%)
Sites        tested    Shigella (%) S. flexneri S. sonnei S. dysenteriae
Jakarta 2495 122 (5)   97 (80) 17 (14)   8 (6)
Makassar   146     4 (3)     3 (75)   1 (25)   0 (0)
Denpasar (2)   607   35 (6)   29 (83)   2 (6)   4 (11)
Pontianak   330   16 (5)   13 (81)   2 (13)   1 (6)
Batam     99     1 (1)     0 (0)   0 (0)   1 (100)
Padang     51     2 (4)     2 (100)   0 (0)   0 (0)
Medan   120     0 (0)     0 (0)   0 (0)   0 (0)
Total 3848 180 (5) 144 (80) 22 (12) 14 (8)139 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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misuse of antibiotic drug therapies. The spread of
drug resistance is the result of poorly regulated
and enforced policies. Resistance to nalidixic acid
(100%) among isolates of S. dysenteriae has been
reported in Bangladesh (13); however, we found
no such resistance. Nevertheless, other data from
Indonesia indicate increasing resistance. In a
previous report (8), 72% of Shigella spp. were
resistant to tetracycline, but less than 30% were
resistant to chloramphenicol, trimethroprim-
sulfamethoxazole, or ampicillin. Previous studies
from Bangladesh and Tanzania (13,6) showed
that almost all tested isolates were resistant to
the antibiotics used for treatment. Similar
antimicrobial resistance profiles for Shigella spp.
were reported from Thailand (14), where high
resistance to ampicillin, trimethroprim-
sulfamethoxazole, chloramphenicol, and tetracy-
cline was documented.
The reemergence of S. dysenteriae from
several locations in Indonesia should prove cause
for concern to health officials, particularly in
monitoring acute, debilitating diarrheal out-
breaks. The epidemic potential attributed to
S. dysenteriae, as documented in Central America,
Asia, and Africa, in conjunction with notably high
death rates, warrants close attention to this
reemerging pathogen in Indonesia (13,15,16).
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